Form 4 for CORT CORCEPT THERAPEUTICS INC
Accepted 2025-08-05 00:00:00 ET · period of report 2025-06-12 · accession 0000950170-25-103324 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DTI | 2025-08-05 | 2025-07-03 | CORT | Maduck Sean | See Remarks | G - Gift | $0.00 | -40.0K | 59.7K | -40% | $0 |
| DMT | 2025-08-05 | 2025-08-01 | CORT | Maduck Sean | See Remarks | S - Sale+OE | $67.79 | -35.0K | 7,681 | -82% | -$2.37M |
| DT | 2025-08-05 | 2025-06-12 | CORT | Maduck Sean | See Remarks | G - Gift | $0.00 | -10.0K | 7,681 | -57% | $0 |
| DMTI | 2025-08-05 | 2025-06-12+ | CORT | Maduck Sean | See Remarks | J - Other | $0.00 | +50.0K | 40.0K | New | $0 |
| DT | 2025-08-05 | 2025-08-01 | CORT | Maduck Sean | See Remarks | M - OptEx | $5.05 | +35.0K | 42.7K | +456% | +$176.8K |
| DT | 2025-08-05 | 2025-08-01 | CORT | Maduck Sean | See Remarks | M - OptEx | $0.00 | -35.0K | 22.0K | -61% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-07-03 | G | D | 40,000 | $0.00 | 59,717 | I See Footnote | — | — | (F5) Represents the shares held by SNM 2025 Grantor Retained Annuity Trust of which the Reporting Person is the trustee. |
| 2 | Common | Common Stock | 2025-08-01 | S | D | 5,428 | $68.52 | 9,395 | D | — | — | (F8) Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $68.17 to $69.13 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request. |
| 3 | Common | Common Stock | 2025-08-01 | S | D | 27,865 | $67.53 | 14,823 | D | — | — | (F7) Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $67.17 to $68.10 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request. |
| 4 | Common | Common Stock | 2025-06-12 | G | D | 10,024 | $0.00 | 7,681 | D See Footnote | — | — | (F1) Includes 458 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 3, 2024, 265 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 2, 2024, 266 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 3, 2025 and 888 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 2, 2025. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements. (F3) Represents the shares held by Sean and Molly Maduck Living Trust of which the Reporting Person is a co-trustee. |
| 5 | Common | Common Stock | 2025-06-12 | J | A | 10,024 | $0.00 | 99,717 | I See Footnote | — | — | (F3) Represents the shares held by Sean and Molly Maduck Living Trust of which the Reporting Person is a co-trustee. |
| 6 | Common | Common Stock | 2025-08-01 | S | D | 1,714 | $69.70 | 7,681 | D | — | — | (F9) Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $69.48 to $69.74 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request. |
| 7 | Common | Common Stock | 2025-07-03 | J | A | 40,000 | $0.00 | 40,000 | I | — | — | |
| 8 | Common | Common Stock | 2025-08-01 | M | A | 35,007 | $5.05 | 42,688 | D | — | — | |
| 9 | Derivative | Stock option (right to buy) | 2025-08-01 | M | D | 35,007 | $0.00 | 21,986 | D | $5.05 · — to 2026-05-02 | 35,007 Common Stock | (F11) Fully exercisable. |